1987
DOI: 10.1002/tera.1420350319
|View full text |Cite
|
Sign up to set email alerts
|

Valproic acid

Abstract: Valproic acid use during pregnancy results in an absolute risk for spina bifida of 1-2%. This increased risk is comparable to the recurrence risk for neural tube defects and warrants informed counselling and access to prenatal diagnosis. There is no substantial evidence that valproic acid use increases the risk for other specific major malformations above the increased risk due to maternal epilepsy. Valproic acid may cause a characteristic pattern of minor facial malformations. Further definition and confirmat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
30
0

Year Published

1996
1996
2011
2011

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 256 publications
(35 citation statements)
references
References 36 publications
1
30
0
Order By: Relevance
“…Estimations of prevalence of NTD due to exposure to the anticonvulsant valproic acid range from 1 to 2% and with carbamazepine exposure at about 0.5% [12, 13]. These rates are about 10 times higher than the population rate.…”
Section: What Causes Ntds?mentioning
confidence: 94%
“…Estimations of prevalence of NTD due to exposure to the anticonvulsant valproic acid range from 1 to 2% and with carbamazepine exposure at about 0.5% [12, 13]. These rates are about 10 times higher than the population rate.…”
Section: What Causes Ntds?mentioning
confidence: 94%
“…Valproic acid (VPA) (2-propyl pentanoic acid), widely used in treating epilepsy and bipolar disorder, 8,9) has recently received attention as an anti-tumor agent, 10) but it causes hepatic damage, pancreatitis, hyperammonemia, and depression of the central nervous system, 11) and exposure to it in early pregnancy is a risk factor for spina bifida 12,13) and autism. 14,15) Although histone deacetylase 16) and glycogen synthase kinase 3 17,18) have been reported to be intracellular targets of VPA, the mechanisms responsible for the side effects of VPA are not well understood.…”
mentioning
confidence: 99%
“…In this study we used spotted cDNA microarrays to monitor global gene expression changes in response to the antiepileptic drug valproic acid (VPA), a potent teratogen that most notably induces neural tube defects (NTDs) in human, mouse, and other vertebrate embryos (Lammer et al 1987; Nau et al 1991; Oberemm and Kirschbaum 1992; Whitsel et al 2002). NTDs with varying penetrance can be induced in the mouse embryo by many chemical treatments (Copp et al 1990) and by the functional disruption of a plethora of genes (Copp et al 2003; Juriloff and Harris 2000).…”
mentioning
confidence: 99%